Angelini – CDMO – CRDMO: Tools and different business model for new opportunity in synthesis
28 July 2023
No Comments
INTRODUCTION The active pharmaceutical ingredient (API) is the foundation of a final drug product
Issue: July / August 2023
Better inorganic growth in chemicals and life sciences – Accelerating growth with a best-in-class acquisition process
28 July 2023
No Comments
This article is based on a talk, panel discussion, and networking event that took place in London in March 2023, co-hosted by corporate development consultancy CCD Partners and trans-Atlantic law firm Womble Bond Dickinson, in association with Women in Chemicals.
Bioinformatics and AI in the service of genetics
27 July 2023
No Comments
OVERVIEW According to WHO data, there are up to 8,000 rare diseases, most of
Chemical engineering, catalysis and flow chemistry for human space exploration
27 July 2023
No Comments
The expectation that humans might soon go to moon and in some time even